Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

InspireMD (NSPR) Asset Writedowns and Impairment (2015)

InspireMD posted quarterly Asset Writedowns and Impairment of $260000.0 for Q3 2015, down 17.72% on a QoQ basis from $316000.0 in Q1 2015.

InspireMD (NSPR) has 1 years of Asset Writedowns and Impairment data on file, last reported at $260000.0 in Q3 2015.

  • For the quarter ending Q3 2015, Asset Writedowns and Impairment changed N/A year-over-year to $260000.0; the trailing twelve-month figure through Dec 2015 stood at $576000.0 (changed N/A YoY), and the FY2015 full-year result was $576000.0, changed N/A from the prior year.
  • Asset Writedowns and Impairment for Q3 2015 stood at $260000.0, down from $316000.0 in the prior quarter.
  • Across five years, Asset Writedowns and Impairment topped out at $316000.0 in Q1 2015 and bottomed at $260000.0 in Q3 2015.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 InspireMD 64.01 Mn 9.80 Mn 1.18 Mn

Historic Data

Download Data 🔒
DateValue
Sep 30, 2015 260,000.00
Sep 30, 2015 260,000.00
Mar 31, 2015 316,000.00
Mar 31, 2015 316,000.00